VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Morphine as IVPCA
Preclinical
Small molecule
M
Mount Sinai Hospital, Canada
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Orthopedic Procedures
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Orthopedic Procedures
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Orthopedic Procedures
1 trial
Does IVPCA Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?
Unknown status
·
M
Mount Sinai Hospital, Canada
·
N/A
·
NCT02880800
·
80 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Morphine as IVPCA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Morphine as IVPCA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Morphine as IVPCA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Mount Sinai Hospital, Canada company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
M
Mount Sinai Hospital, Canada
Related News